Anthem Blue Cross ConnecticutCommercial Clinical Policy

GENE.00023 Gene Expression Profiling of Melanomas and Cutaneous Squamous Cell Carcinoma Form

Chat with GenHealth to automate any policy or prior auth task.

Effective Date

06/28/2023

Last Reviewed

05/11/2023

Original Document

  Reference



This document addresses gene expression profiling to assist in determining the diagnosis, risk stratification and clinical management of cutaneous and uveal (ocular) melanoma and cutaneous squamous cell carcinoma.

Position Statement

Investigational and Not Medically Necessary:

  1. Gene expression profiling of suspected or established cutaneous melanoma is considered investigational and not medically necessary.
     
  2. Gene expression profiling of suspected or established uveal melanoma is considered investigational and not medically necessary.
     
  3. Gene expression profiling of suspected or established cutaneous squamous cell carcinoma is considered investigational and not medically necessary.

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.